ReposiTrak, Inc. (TRAK) AI Stock Analysis

ReposiTrak, Inc., formerly known as Park City Group, Inc., is a software-as-a-service provider based in Murray, Utah. The company designs, develops, and markets proprietary software solutions across North America. Key offerings include ReposiTrak MarketPlace for B2B supplier discovery, as well as Compliance and Food Safety solutions to mitigate regulatory and legal supply chain risks. Its Supply Chain solutions help multi-store retail chains, wholesalers, and distributors manage supplier relationships, inventory, assortment, and labor allocation. Tools include ScoreTracker, Vendor Managed Inventory, Fresh Market Manager, Audit Management, and ActionManager, alongside strategic business consulting services.

Between FY2022 and FY2026, ReposiTrak expanded annual revenue from $18.0M to $23.3M, representing a 5-year revenue CAGR of 2.1%. Gross margin expanded steadily from 82.3% in FY2022 to 85.8% in FY2026, while operating margin grew from 24.5% to 33.7%. Net income rose from $4.0M in FY2022 to $7.6M in FY2026, lifting diluted EPS from $0.21 to $0.39. In FY2026, revenue increased 3.0% over FY2025 revenue of $22.6M. However, in the latest quarter ending June 30, 2026, quarterly revenue growth declined 3.2% year-over-year, while quarterly earnings growth increased 22.4%.

ReposiTrak holds a liquid balance sheet as of June 30, 2026, with cash and short-term investments of $27.3M and total debt of $294,340, resulting in net cash of $27.0M. Its current ratio is 3.85, and debt-to-equity is 0.01 against shareholders' equity of $52.3M. In FY2026, the company generated $8.2M in operating cash flow and $8.2M in free cash flow, with capital expenditures of only $16,594. Cash was returned to shareholders via $3.7M in share buybacks and $1.6M in dividends paid.

TRAK trades at a trailing P/E of 18.5x and a forward P/E of 16.8x, compared to medians of 28.1x and 18.8x for its US-listed Technology peers. Its enterprise value of $123.3M reflects an EV/EBITDA of 12.6x, below the peer median of 16.6x. Conversely, its price-to-sales multiple of 5.6x trades at a premium to the peer median of 2.8x. Over the past year, TRAK shares fell 49.1%, significantly trailing the 16.8% gain for the S&P 500 (SPY). Over five years, TRAK gained 31.8% versus 83.0% for the index.

ReposiTrak pays a quarterly dividend with an annual forward payout of $0.08 per share, yielding 1.11% as of October 16, 2026. The company has paid consecutive dividends for 5 years, supported by a modest payout ratio of 20.5% and FY2026 dividends paid of $1.6M. Its last ex-dividend date was September 30, 2026.

Wall Street coverage includes 1 analyst with a Buy rating. The mean price target is $16.00, implying a 122.2% upside from the last close of $7.20. For the current fiscal year ending June 30, 2027, consensus estimates forecast revenue of $25.5M and EPS of $0.43, reflecting 10.3% earnings growth. Over the last four quarters, ReposiTrak delivered 2 EPS beats. The company's next earnings report is scheduled for November 12, 2026.

This page is an AI-written research summary of ReposiTrak, Inc. (TRAK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: TRAK income statement, TRAK balance sheet, TRAK key metrics, TRAK analyst forecast, TRAK chart. See the TRAK stock overview for the latest quote and news.